Jiangsu Recbio Technology Co Ltd (2179)

Hong Kong
Currency in HKD
7.49
+0.11(+1.49%)
Delayed Data·
2179 Scorecard
Full Analysis
Stock price often moves in the opposite direction of the market
Fair Value
Day's Range
7.287.50
52 wk Range
6.769.97
Key Statistics
Edit
Bid/Ask
7.34 / 7.50
Prev. Close
7.38
Open
7.28
Day's Range
7.28-7.5
52 wk Range
6.76-9.97
Volume
16K
Average Volume (3m)
139.46K
1-Year Change
-19.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2179 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Jiangsu Recbio Technology Co Ltd Company Profile

Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China. The company is developing vaccines for the treatment of cervical cancer, and anal and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in phase III clinical trial; REC601 and REC602 recombinant HPV bivalent vaccines, which are in phase I clinical trials; REC604a, a recombinant HPV quadrivalent vaccine that is in pre-clinical stage; and REC604b, a recombinant HPV 9-valent vaccine that is in pre-clinical stage. It also develops ReCOV, a recombinant COVID-19 vaccine candidate that is in Phase II/III trial; R520A, a messenger ribonucleic acid COVID-19 vaccine candidate that is in pre-clinical stage; REC610, a recombinant shingles vaccine that is in Phase l clinical trial; REC607, a virus vectored adult tuberculosis vaccine that is in pre-clinical stage; REC606, a recombinant adult tuberculosis vaccine that is in pre-clinical stage; REC617, a recombinant influenza quadrivalent vaccine that is in pre-clinical stage; and REC605, a recombinant hand-foot-mouth disease quadrivalent vaccine that is in pre-clinical stage. Jiangsu Recbio Technology Co., Ltd. was founded in 2011 and is headquartered in Taizhou, the People’s Republic of China.

Compare 2179 to Peers and Sector

Metrics to compare
2179
Peers
Sector
Relationship
P/E Ratio
−6.0x−9.4x−0.5x
PEG Ratio
−2.910.280.00
Price/Book
6.3x5.3x2.6x
Price / LTM Sales
123.0x10.6x2.9x
Upside (Analyst Target)
76.0%31.4%58.9%
Fair Value Upside
Unlock−3.3%8.0%Unlock

Earnings

Latest Release
Mar 28, 2025
EPS / Forecast
-0.64 / --
Revenue / Forecast
9.39M / --
EPS Revisions
Last 90 days

FAQ

What Is the Jiangsu Recbio Technology (2179) Stock Price Today?

The Jiangsu Recbio Technology stock price today is 7.49

What Stock Exchange Does Jiangsu Recbio Technology Trade On?

Jiangsu Recbio Technology is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Jiangsu Recbio Technology?

The stock symbol for Jiangsu Recbio Technology is "2179."

What Is the Jiangsu Recbio Technology Market Cap?

As of today, Jiangsu Recbio Technology market cap is 3.43B.

What is Jiangsu Recbio Technology Earnings Per Share?

The Jiangsu Recbio Technology EPS is -1.16.

From a Technical Analysis Perspective, Is 2179 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.